J C

A study published yesterday in the journal Vaccine titled “Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.”

The researchers used Pfizer and Moderna’s own randomized, placebo-controlled trials and compared them against an industry list of common adverse events following vaccination. Guess what they found?

Combined, there was a 16% higher risk of serious adverse events in mRNA vaccine recipients … points to the need for formal harm-benefit analyses … release of participant level datasets… The Pfizer trial exhibited a 36% higher risk of serious adverse events in the vaccine group[.]
That’s not good for business.

You can add this study to the ever-growing list of journal articles critical of the jabs. Remember: jab-critical studies have been embargoed until just recently; journal editors have simply refused to print them because they “could cause vaccine hesitancy.”

Something is changing